Saturday 10 October 2026 Export all IDXG data to Excel Powerpack

Interpace Biosciences, Inc.

IDXG

Interpace Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $38.7 million, down 17.5% from fiscal 2024. In the quarter to June 2026, revenue fell 1.09%, EPS grew 104.1% and free cash flow fell 92.1%, each against the same quarter a year earlier. Operating cash flow growth for five consecutive years.

6.00 0.00 0.00%

Follow IDXG

Alert me

Market cap: —
P/E: 0.2×
Fwd P/E: —
Dividend yield: —
F-score: 5/9
Altman Z: −6.95
Beneish M: 2.07
Dividend safety: n/a

Overview Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.06	0.07	0.04	0.21	+8 more quarters Free account
P/S ratio Full definition →	0.25	0.24	0.03	0.02
P/FCF ratio Full definition →	2.20	1.93	0.22	0.20
P/Operating CF Full definition →	92.15	30.44	0.51	0.41
P/B ratio Full definition →	0.39	0.37	0.05	0.00
Price to Tangible BV Full definition →	0.39	0.37	0.05	0.00
EV/Sales Full definition →	0.25	0.24	0.04	0.05
EV/EBITDA Full definition →	1.80	2.06	0.29	0.41
EV/Operating CF Full definition →	2.06	1.81	0.24	0.45
EV/FCF Full definition →	2.24	1.98	0.28	0.57
Quick Ratio Full definition →	1.82	2.16	1.60	1.24
Current Ratio Full definition →	2.22	2.51	1.94	1.54
Net Debt/EBITDA Full definition →	(4.83)	(1.96)	(1.38)	(1.04)
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	1.54	1.51	1.59	3.21
Operating CF/Net income Full definition →	0.62	0.39	0.09	2.13
Capex/Depreciation Full definition →	(0.24)	(0.63)	(0.16)	(0.52)
Research and Development Expense of Revenue Full definition →	1.63%	1.69%	1.54%	1.71%
Selling, General and Administrative Expense of Revenue Full definition →	56.76%	51.24%	46.88%	47.33%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	0.04%	0.04%	0.04%	0.08%
Graham Net Nets Full definition →	(0.04)	(0.04)	(1.45)	(4.02)
Graham Number Full definition →	50.33	54.54	125.75	0.00
Earnings Yield Full definition →	1,646.26%	1,381.25%	2,260.62%	481.81%
Free Cash Flow Yield Full definition →	45.45%	51.71%	461.73%	491.15%
Revenue per Share Full definition →	1.65	1.98	10.43	9.89
Operating CF per Share Full definition →	0.02	0.06	2.42	2.19
Capex per Share Full definition →	(0.01)	(0.03)	(0.04)	(0.13)
Free Cash Flow per Share Full definition →	0.01	0.03	2.37	2.06
Cash per Share Full definition →	0.49	0.58	2.83	1.61
Shareholders Equity per Share Full definition →	4.20	5.07	25.27	(0.34)
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	4.20	5.07	25.27	(0.34)
Free Cash Flow Full definition →	0.04	0.14	2.10	1.82
Working Capital Full definition →	6.02	6.00	4.80	3.19
Capital Expenditures Full definition →	(0.06)	(0.14)	(0.04)	(0.12)
Net Current Asset Value Full definition →	(0.34)	(0.36)	(1.57)	(3.20)
EV/EBIT Full definition →	2.20	2.61	0.35	0.49
Capex to Sales Full definition →	0.01	0.02	0.00	0.01
Price to Operating Income Full definition →	2.17	2.55	0.27	0.17
Other line items
Average Receivables Full definition →	6.77	7.35	7.10	6.63
Average Payables Full definition →	1.40	1.27	1.32	1.56
Average Assets Full definition →	23.44	23.95	24.32	13.04
Average Common Equity Full definition →	11.02	11.25	10.07	(28.99)

Fold the line items

Columns are period end dates · fundamentals updated 28 Sep 2026

Stockrow Weekly